Evidence map›Paper›PMID 34494886›Full record

ArticlemSphere2021

Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission.

Laura Pérez Lago, Leire Pérez Latorre, Marta Herranz, Francisco Tejerina, Pedro J Sola-Campoy, Jon Sicilia, Julia Suárez-González, Cristina Andrés-Zayas, Alvaro Chiner-Oms, Santiago Jiménez-Serrano and 8 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. A simple but complex enoughPhysica D. Nonlinear phenomena · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Laura Pérez Lago *Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Leire Pérez Latorre *Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Marta HerranzServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Francisco TejerinaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Pedro J Sola-CampoyServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Jon SiciliaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Julia Suárez-GonzálezInstituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Cristina Andrés-ZayasInstituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Alvaro Chiner-OmsInstituto de Biomedicina de Valencia-CSIC, Valencia, Spain.
Santiago Jiménez-SerranoInstituto de Biomedicina de Valencia-CSIC, Valencia, Spain.
Neris García-GonzálezJoint Research Unit Infection and Public Health FISABIO-University of Valencia, Institute for Integrative Systems Biology (I2SysBio), Valencia, Spain.ORCID 0000-0001-9089-4033
Iñaki ComasInstituto de Biomedicina de Valencia-CSIC, Valencia, Spain.ORCID 0000-0001-5504-9408
Fernando González-CandelasJoint Research Unit Infection and Public Health FISABIO-University of Valencia, Institute for Integrative Systems Biology (I2SysBio), Valencia, Spain.ORCID 0000-0002-0879-5798
Carolina Martínez-LapercheInstituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Pilar CatalánServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Patricia MuñozServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
Darío García de ViedmaServicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.ORCID 0000-0003-3647-7110
Gregorio Marañón Microbiology-ID COVID 19 Study Group
Hospital General Universitario Gregorio Marañón · ESInstituto de Biomedicina de Valencia · ESUniversitat de València · ESUniversidad Complutense de Madrid · ES

Funding

MEC | Instituto de Salud Carlos III (ISCIII) COV20/00140
6 · The paper itself

Abstract

The first descriptions of reinfection by SARS-CoV-2 have been recently reported. However, these studies focus exclusively on the reinfected case, without considering the epidemiological context of the event. Our objectives were to perform a complete analysis of the sequential infections and community transmission events around a SARS-CoV-2 reinfection, including the infection events preceding it, the exposure, and subsequent transmissions. Our analysis was supported by host genetics, viral whole-genome sequencing, phylogenomic viral population analysis, and refined epidemiological data obtained from interviews with the involved subjects. The reinfection involved a 53-year-old woman with asthma (Case A), with a first COVID-19 episode in April 2020 and a much more severe second episode 4-1/2 months later, with SARS-CoV-2 seroconversion in August, that required hospital admission. An extended genomic analysis allowed us to demonstrate that the strain involved in Case A's reinfection was circulating in the epidemiological context of Case A and was also transmitted subsequently from Case A to her family context. The reinfection was also supported by a phylogenetic analysis, including 348 strains from Madrid, which revealed that the strain involved in the reinfection was circulating by the time Case A suffered the second episode, August-September 2020, but absent at the time range corresponding to Case A's first episode.

Indexed as

Contact TracingCOVID-19FamilyFemaleGenomicsHumansMaleMiddle AgedPhylogenyReinfectionSARS-CoV-2Severity of Illness IndexSpainWhole Genome SequencingCOVID-19genomicsreinfectionSARS-CoV-2transmission

Identifiers

PMID34494886
PMCPMC8550076
OpenAlexW3108643572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.